ROYAL BANK OF CANADA - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 69 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,000
-37.5%
3,842
+6.9%
0.00%
Q2 2023$24,0003,594
+71780.0%
0.00%
Q1 2023$050.0%0.00%
Q4 2022$0
-100.0%
5
-99.6%
0.00%
Q1 2022$4,000
-85.7%
1,260
-69.4%
0.00%
Q4 2021$28,000
+21.7%
4,121
+76.1%
0.00%
Q3 2021$23,000
-25.8%
2,340
+135.6%
0.00%
Q2 2021$31,000
-39.2%
993
-14.2%
0.00%
Q1 2021$51,0001,1580.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Nextech Invest Ltd. 1,910,029$10,085,0003.26%
K2 PRINCIPAL FUND, L.P. 3,247,533$16,890,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,045,234$5,519,0001.09%
Orbimed Advisors 8,740,887$46,152,0000.86%
Rubric Capital Management LP 2,695,170$14,230,0000.72%
Prosight Management, LP 196,257$1,036,0000.56%
Nantahala Capital Management 1,249,863$6,599,0000.43%
Oasis Management Co Ltd. 317,662$1,677,0000.28%
TANG CAPITAL MANAGEMENT LLC 409,463$2,162,0000.26%
APOGEM CAPITAL LLC 13,793$73,0000.07%
View complete list of SILVERBACK THERAPEUTICS INC shareholders